Page last updated: 2024-08-18

phenformin and bi-78d3

phenformin has been researched along with bi-78d3 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, S; Chen, Y; Fu, L; He, G; Liu, B1

Reviews

1 review(s) available for phenformin and bi-78d3

ArticleYear
Targeting Extracellular Signal-Regulated Protein Kinase 1/2 (ERK1/2) in Cancer: An Update on Pharmacological Small-Molecule Inhibitors.
    Journal of medicinal chemistry, 2022, 10-27, Volume: 65, Issue:20

    Topics: Extracellular Signal-Regulated MAP Kinases; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Neoplasms; Protein Kinase Inhibitors; Signal Transduction

2022
chemdatabank.com